The purpose of this review is to provide arguments in favor of a more liberal approach to the treatment of late stage Lyme disease, specifically the use of intravenous antibiotics for extended periods of time.
Lyme borreliosis (Lyme disease) is a multisystem illness caused by the spirochete Borrelia burgdorferi. Although dermatologic, articular, cardiac, opthalmologic, and neurologic manifestations are well known, it is less well known that psychiatric disorders may also arise as a result of borrelial infection (1). Depression (2), panic attacks (3), schizophrenia-like psychotic state (4), bipolar disorder (3), […]
Millions of people who are diagnosed with multiple sclerosis, fibromyalgia, Alzheimer’s, chronic fatigue syndrome and other degenerative diseases could have Lyme Disease causing or contributing to their condition.
In the last decade the majority of outcome-oriented physicians observed a major shift: we realized that it was neither the lack of vitamins or growth hormone that made our patients ill. We discovered that toxicity and chronic infections were most often at the core of the client’s suffering. We watched the discussion, which infection may […]
Newer approaches to the treatment of Lyme disease should take into account its clinical complexity in coinfected patients and the possible need for prolonged combination therapy in patients with persistent symptoms of this potentially debilitating illness. The optimal antibiotic regimen for chronic Lyme disease remains to be determined.
The first section of this paper will provide an overview of Lyme borreliosis and a review of the relevant neuropsychiatric literature. The second section will provide clinical descriptions of some common neuropsychiatric symptoms as well as a discussion of the problems typically faced by patients with this illness. Guidelines to assist the clinician in working […]